Home › Biotechnology › Biomarkers
Biomarkers Market Research Reports & Consulting
Biomarkers play a vital role in diagnosis and drug discovery. The reports in this category cover the markets for biomarker applications, technologies, products, and services. The biomarker applications segment covers markets such as personalized medicine and the diagnosis and treatment markets for various disease conditions such as cancer, cardiovascular diseases, neurological disorders, and autoimmune diseases. The applications segment also includes the drug discovery market, which in turn covers submarkets such as drug targets, ADME-TOX profiling, and process quality assurance in drug development.
The biomarker technologies segment is classified into the pre-genomic and post-genomic technology markets. The former includes technologies such as enzyme and metabolite assays, immunodiagnostics, and molecular diagnostics; while the latter includes technologies such as transcriptomics, metabolites and imaging biomarkers. The biomarker services segment is bifurcated into the markets for pre- and post-clinical services such as sample preparation, mRNA analysis and miRNA analysis, antibody development, assay development and production, and validation and reporting.
Our research reports analyze and forecast the revenues for all of these markets; and also provide comprehensive data on the factors affecting market growth, such as regulatory issues on genomics, proteomics, and molecular diagnostics in various geographies.
Market Reports
| Title | Published | Price | TOC Available |
|---|---|---|---|
Biomarkers Market (Discovery Technologies, Applications & Indications) – Global Trends, Opportunities & Forecasts (2011 – 2020)A biomarker is defined as a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacologic response to a therapeutic intervention. Biomarkers are classified in different ways based on different parameters such as on the basis of their application, their characteristics and on their usage in decision making in early drug development. With drug development facing challenges from ever increasing cost of developing drugs and rise in the failure rate for drugs in phase II and III clinical trials, biomarkers are being employed on large scale by pharmaceutical companies to overcome these challenges. Also the advent of personalized medicine and companion diagnostics is witnessing a strong presence of use of biomarkers and holds to be a big opportunity for the overall biomarker market. |
January 2012 | $ 4650 |
|
Biochips Market (DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & Cell Arrays) Trends & Global Forecast (2010-2015)The report analyzes the various product segments under the broader biochips market, including lab chips, DNA chips etc. Market analysis includes over 100 market data tables that examine the biochips industry by products and geographies. The report has also profiles the key players and the competitive landscape in detail. |
August 2011 | $ 4650 |
|
Global Cancer Biomarkers Market (2010 - 2015)Cancer is recognized as a major cause of mortality world over; accounting for 7.4 million (or 13%) of all deaths in 2004. The WHO estimates the incidence of cancer to continue rising to reach an estimated 9.2 million deaths in 2015. The rising prevalence of the disease forms one of the major factors driving the growth of the oncology biomarkers market. |
June 2010 | $ 4650 |
|
Lab-on-Chip (Microfluidics) Market (2011-2016)A lab-on-chip (LOC) device is a miniaturized laboratory on a credit card sized chip with a network of micro-channels, electrodes, sensors, and electronic circuits. These chips are usually made of polymer, glass, Silicon, plastic, and other materials. LOC has evolved from MEMS (Micro electro mechanical systems) devices and can replicate all the functions of its counterparts in performing several clinical diagnostics tests. The lab-on-chip market is a fast growing segment of the global biochip market as its wide applications have led to increased adoption in pharmaceutical, biotechnology companies, and other research laboratories. Furthermore, these chips are not limited to human applications but are very suitable for a variety of veterinary needs, food safety, and environmental testing in industrial as well as remote areas. Diagnostics represents the largest potential application market for lab-on-chips growing at a CAGR of 22.6%. |
March 2012 | $ 4650 | |
Global Fungicides Market by Active Ingredient Type, Cereal, Regulations Trends and Opportunities (2010 – 2015)Global Fungicides Market has been gradually turning better with the increasing demand from agricultural market. Meanwhile, the domestic demand for fungicides in most of countries like china, India 2011 is estimated to be higher than that of 2010, with the prediction of more serious disease occurrence. However, the competition of fungicide industry in key growth regions will be increasingly fierce in coming years as more and more players getting into fungicide business. |
March 2012 | $ 4650 |
|
Custom Research
We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.
Please visit http://www.marketsandmarkets.com/custom-research.asp to specify your custom Research Requirement
Connect Us
